Sign in:
 Email
 Password  save:
  
 Company Reports 
 
 
Membership is free, please Sign Up.
  
My Recent Searches
  Help
  
   
 
 
Get Insiders for : 
Nabriva Therapeutics AG (NBRV)  
$0.39 0.00 (0.00%) as of 4:30 Wed 12/2


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 150,780,000
Market Cap: 59.38(M)
Last Volume: 0 Avg Vol: 0
52 Week Range: $0.3938 - $0.3938
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:
   

Rankings:
     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

            6 Months   1 Year   2 Year  
 
Company Profile   Nabriva Therapeutics is a holding company. Through its subsidiaries, Co. is a biopharmaceutical company engaged in the research, development and commercialization of anti-infective agents to treat serious infections. Co. has approval from the U.S. Food and Drug Administration for XENLETA for the treatment of adults with community-acquired bacterial pneumonia. XENLETA is an oral and intravenous treatment in the pleuromutilin class of antibiotics available for the systematic administration in humans. Co.'s CONTEPO is a potentially epoxide antibiotic for intravenous use in the U.S. for complicated urinary tract infections. Co. may develop XENLETA and CONTEPO for additional indications.

 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 0
Total Buy Value $0 $0 $0 $0
Total People Bought 0 0 0 0
Total Buy Transactions 0 0 0 0
Total Shares Sold 0 0 0 51,839
Total Sell Value $0 $0 $0 $9,588
Total People Sold 0 0 0 6
Total Sell Transactions 0 0 0 6
End Date 2024-02-18 2023-11-17 2023-05-19 2022-05-19

   
Records found: 323
  Page 12 of 13  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

  
3m +/-  
Form
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-08-07 4 S $10.50 $186,795 D/D (17,790) 2,373,387     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-07-28 4 S $10.51 $69,195 D/D (6,585) 2,391,177     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-07-24 4 S $10.50 $1,680 D/D (160) 2,397,762     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-07-20 4 S $10.50 $246,173 D/D (23,445) 2,397,922     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-07-19 4 S $10.50 $218,253 D/D (20,786) 2,421,367     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-07-03 4 S $10.95 $124,250 D/D (11,352) 2,571,877     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-06-30 4 S $10.94 $19,420 D/D (1,775) 2,583,229     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-06-29 4 S $10.72 $17,189 D/D (1,603) 2,585,004     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-06-28 4 S $11.10 $53,158 D/D (4,789) 2,586,697     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-06-27 4 S $10.83 $23,457 D/D (2,166) 2,591,396     -
   Talbot George Harrison Director   –       •      –    2017-06-19 4 S $91.00 $4,186 D/D (46) 3,179     -
   Talbot George Harrison Director   –       •      –    2017-06-16 4 S $93.50 $2,244 D/D (24) 3,225     -
   Talbot George Harrison Director   –       •      –    2017-06-15 4 S $94.10 $9,410 D/D (100) 3,249     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-06-01 4 S $11.27 $4,508 D/D (400) 2,593,562     -
   Talbot George Harrison Director   –       •      –    2017-05-30 4 S $101.00 $21,265 D/D (210) 3,349     -
   Talbot George Harrison Director   –       •      –    2017-05-25 4 S $100.50 $29,693 D/D (295) 3,559     -
   Talbot George Harrison Director   –       •      –    2017-05-23 4 S $99.70 $2,991 D/D (30) 3,854     -
   Talbot George Harrison Director   –       •      –    2017-05-16 4 S $102.27 $15,413 D/D (150) 3,884     -
   Talbot George Harrison Director   –       •      –    2017-05-15 4 S $101.50 $5,075 D/D (50) 4,034     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-04-28 4 S $11.03 $166,813 D/D (15,130) 2,593,962     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-04-27 4 S $11.00 $1,100 D/D (100) 2,609,092     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-04-26 4 S $11.00 $7,799 D/D (709) 2,609,192     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-04-21 4 S $11.04 $28,937 D/D (2,622) 2,609,901     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-04-20 4 S $11.00 $3,575 D/D (325) 2,612,523     -
   Hbm Bioventures Cayman Ltd 10% Owner   –       –       •   2017-04-19 4 S $11.07 $130,434 D/D (11,785) 2,612,848     -
  323 Records found
  Previous  10  11  12  13   
  Page 12 of 13
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed
 
 
    Copyright © 2024 j3sg.com | Disclaimer & Terms of use          Products & Service  About Us  Contact Us